Unlike EBRT, brachytherapy involves placing a radiation source internally, either into or immediately next to the tumor. The word ‘brachy’ is Greek for ‘short-distance’, and it is the short distance between the radiation source and the cancerous tumor which enables brachytherapy to offer highly precise, effective and safe radiotherapy.
First practiced over 100 years ago, modern brachytherapy utilizes a combination of state-of-the-art imaging, computer-based planning and treatment delivery technologies to deliver optimal radiotherapy.
Brachytherapy provides an effective choice in the treatment of cancers of many different body sites.2
It is most commonly used in the treatment of cervical, prostate, breast and skin cancers, but is increasingly being used for cancers of many other body sites.
This radiation dose can be delivered directly to the tumor site precisely, efficiently and safely, providing cancer cure rates comparable to surgery and EBRT. Furthermore, the precision of brachytherapy minimizes the exposure of surrounding healthy tissues to unnecessary radiation.3 The potential risk of side effects is reduced in comparison with surgery and EBRT.4,5
Brachytherapy also enables higher radiation doses to be given safely in a shorter period of time. A course of brachytherapy can typically be completed in 1 to 5 days, compared to many weeks with conventional EBRT. Brachytherapy is therefore more time efficient and patient friendly, allowing patients to get back to their everyday life sooner.6,7
This site complies with the HONcode standard for trustworthy health information: verify here.
Please help to improve the information we provide on this site by sharing your feedback.
We hope to provide you with further useful information in the future.